Interestingly, CD163 gene expression was correlated with that of IL12A. This result, suggesting that a high IL12A gene expression was associated with a poor prognosis, was a priori surprising since IL-12 is a cytokine that is known to have immunostimulating functions and has been shown to have a great potential for cancer immunotherapy (47). This evidence concerns the gene IL12A and cancer.